Insights into DCB-Only Strategy for Left Main Coronary Artery Disease
Insights into DCB-Only Strategy for Left Main Coronary Artery Disease

Sanna Uskela and colleagues, from the Heart Center at North Karelia Central Hospital in Finland,.

Non-invasive Ovarian Cancer Detection
Non-invasive Ovarian Cancer Detection & Treatment with Novel Radiotheranostic System

A novel radiotheranostic apparatus possesses the capability to noninvasively detect and address ovarian cancer, as.

FDA approved Iloperidon Bipolar 1 disorder for e
Bipolar 1 Disorder: FDA Approves Iloperidone

Iloperidone (Fanapt) has received FDA approval for the acute treatment of bipolar 1 disorder, according.

Linking IBS and PD: Cohort Study Insights
PD Influence on Irritable Bowel Syndrome: Study Discoveries

Researchers investigate the connection between irritable bowel syndrome (IBS) and Parkinson’s disease (PD) in a.

Duchenne Muscular Dystrophy
FDA Approves Duvyzat Medicine to treat Duchenne Muscular Dystrophy

Duvyzat (givinostat) oral medication was approved today by the United States Food and Drug Administration.

Novel Technique for Human Artificial Chromosomes
Novel Technique for Human Artificial Chromosomes

Human artificial chromosomes (HACs), with the capacity to function within human cells, hold promise for.

Breast Cancer Treatment side effects
Breast Cancer Treatment: AI Tool Predicts Side Effect Risks

An artificial intelligence (AI) tool created by a group of international researchers can identify breast.

Synthetic Biology: Enhancing Nutritional Value, Color, and Flavor
Synthetic Biology: Enhancing Nutritional Value, Color, and Flavor

In a recent publication featured in Nature Communications, scholars have devised a modular synthetic biology.

Exploring the risks and benefits of OTC medications for COVID-19
COVID-19 Over-the-Counter Medication Considerations

The COVID-19 virus can cause symptoms including weariness, fever, coughing, and sore throat. The most.

Liver
FDA Approves Rezdiffra Drug to Treat Liver Disease

Rezdiffra (resmetirom) was approved today by the United States Food and Drug Administration for the.